130 related articles for article (PubMed ID: 16264161)
1. History and molecular genetics of Lynch syndrome in family G: a century later.
Douglas JA; Gruber SB; Meister KA; Bonner J; Watson P; Krush AJ; Lynch HT
JAMA; 2005 Nov; 294(17):2195-202. PubMed ID: 16264161
[TBL] [Abstract][Full Text] [Related]
2. The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome.
Stuckless S; Parfrey PS; Woods MO; Cox J; Fitzgerald GW; Green JS; Green RC
Fam Cancer; 2007; 6(1):1-12. PubMed ID: 17039271
[TBL] [Abstract][Full Text] [Related]
3. A Historical Argument for Changing the Name of a Major Syndrome.
Welling DR
Dis Colon Rectum; 2015 Oct; 58(10):1014-6. PubMed ID: 26347974
[TBL] [Abstract][Full Text] [Related]
4. A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States.
Lynch HT; Coronel SM; Okimoto R; Hampel H; Sweet K; Lynch JF; Barrows A; Wijnen J; van der Klift H; Franken P; Wagner A; Fodde R; de la Chapelle A
JAMA; 2004 Feb; 291(6):718-24. PubMed ID: 14871915
[TBL] [Abstract][Full Text] [Related]
5. A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer.
Froggatt NJ; Green J; Brassett C; Evans DG; Bishop DT; Kolodner R; Maher ER
J Med Genet; 1999 Feb; 36(2):97-102. PubMed ID: 10051005
[TBL] [Abstract][Full Text] [Related]
6. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH
J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634
[TBL] [Abstract][Full Text] [Related]
7. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics and clinical-pathology features of hereditary nonpolyposis colorectal carcinoma (Lynch syndrome): historical journey from pedigree anecdote to molecular genetic confirmation.
Lynch HT; Smyrk T; Lynch JF
Oncology; 1998; 55(2):103-8. PubMed ID: 9499183
[TBL] [Abstract][Full Text] [Related]
9. Characterization of new founder Alu-mediated rearrangements in MSH2 gene associated with a Lynch syndrome phenotype.
Pérez-Cabornero L; Borrás Flores E; Infante Sanz M; Velasco Sampedro E; Acedo Becares A; Lastra Aras E; Cuevas González J; Pineda Riu M; Ramón y Cajal Asensio T; Capellá Munar G; Miner Pino C; Durán Domínguez M
Cancer Prev Res (Phila); 2011 Oct; 4(10):1546-55. PubMed ID: 21778331
[TBL] [Abstract][Full Text] [Related]
10. A century of progress in hereditary nonpolyposis colorectal cancer (Lynch syndrome).
Thorson AG; Knezetic JA; Lynch HT
Dis Colon Rectum; 1999 Jan; 42(1):1-9. PubMed ID: 10211513
[TBL] [Abstract][Full Text] [Related]
11. Hereditary nonpolyposis colorectal cancer with gynecologic malignancies: report of two families in Taiwan.
Chen CH; Huang RL; Yu MS; Wong LJ; Chao TF; Chu TY
J Formos Med Assoc; 2001 Apr; 100(4):269-73. PubMed ID: 11393127
[TBL] [Abstract][Full Text] [Related]
12. Milestones of Lynch syndrome: 1895-2015.
Lynch HT; Snyder CL; Shaw TG; Heinen CD; Hitchins MP
Nat Rev Cancer; 2015 Mar; 15(3):181-94. PubMed ID: 25673086
[TBL] [Abstract][Full Text] [Related]
13. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC).
Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M
Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318
[TBL] [Abstract][Full Text] [Related]
14. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
15. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals pathogenicity due to attenuated mismatch repair.
Wielders EA; Hettinger J; Dekker R; Kets CM; Ligtenberg MJ; Mensenkamp AR; van den Ouweland AM; Prins J; Wagner A; Dinjens WN; Dubbink HJ; van Hest LP; Menko F; Hogervorst F; Verhoef S; te Riele H
J Med Genet; 2014 Apr; 51(4):245-53. PubMed ID: 24501230
[TBL] [Abstract][Full Text] [Related]
17. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy.
Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S
Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463
[TBL] [Abstract][Full Text] [Related]
18. Aldred Scott Warthin: Ann Arbor's Erudite, Outspoken, and Academically Transformative Early 20th Century Pathologist.
Wright JR
Arch Pathol Lab Med; 2021 Oct; 145(10):1297-1306. PubMed ID: 33503235
[TBL] [Abstract][Full Text] [Related]
19. From cancer families to HNPCC: Henry Lynch and the transformations of hereditary cancer, 1975-1999.
Necochea R
Bull Hist Med; 2007; 81(1):267-85. PubMed ID: 17369671
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of urological malignancy in Lynch syndrome.
Barrow PJ; Ingham S; O'Hara C; Green K; McIntyre I; Lalloo F; Hill J; Evans DG
Fam Cancer; 2013 Mar; 12(1):57-63. PubMed ID: 23054215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
